Skip to main content

5 Worst Stocks in the Dow on Tuesday: Walgreens Slips

The worst-performing stocks in the Dow Jones Industrial Average on Tuesday include Walgreens, Goldman Sachs and Walmart.

Stocks were lower Tuesday as investors weighed the passage of the coronavirus relief bill and focused on the impact of the emergence of a new variant of the coronavirus in the U.K. and Europe

Here are the worst stocks in the Dow on Tuesday by their performance in percentage change during trading on Dec. 22.

1. Walgreens WBA | Decreased 3.47%

Last week drugstore chains Walgreens  (WBA) - Get Walgreens Boots Alliance Inc Report and CVS Health  (CVS) - Get CVS Health Corporation Report said they will provide Pfizer's  (PFE) - Get Pfizer Inc. Report coronavirus vaccine to residents of nursing homes and assisted living facilities starting next week, despite scheduling glitches cited by some nursing home operators.

2. Amgen AMGN | Decreased 2.75%

Shares of Amgen AMGN were retreating Tuesday. Last week the biotech company raised its quarterly dividend to $1.76 per share from $1.60 per share.

Scroll to Continue

TheStreet Recommends

3. Goldman Sachs GS | Decreased 2.66%

Banking stocks jumped Monday after the Federal Reserve granted lenders the ability to resume stock repurchases, beginning in the first quarter. Shares of Goldman Sachs  (GS) - Get Goldman Sachs Group, Inc. Report rose 6.80% on Monday during trading hours.

4. Caterpillar CAT | Decreased 2%

Caterpillar  (CAT) - Get Caterpillar Inc. Report is an industrial stock bet that will be good to have if there are improved trade conditions between the U.S. and China. When It comes to China, President-Elect Joe Biden is starting to sound like President Donald Trump, which means this name could be set up for a fall.

5. Chevron CVX | Decreased 1.97%

In December Chevron  (CVX ) - Get Chevron Corporation Reportslashed its near-term capital spending forecasts to shift investment away from traditional crude oil markets and into lower-carbon alternatives. Chevron forecast a 2021 capital spend of around $14 billion including around $300 million in costs linked to the lower carbon transition.

All stock prices and activity referenced are pulled from